Erlotinib mesylate is a kinase inhibitor used in the treatment of non-small cell lung cancer and pancreatic cancer. It specifically targets the epidermal growth factor receptor (EGFR).
183319-69-9
Erlotinib mesylate;CP-358774;NSC 718781;OSI-774;Tarceva
C22H24ClN3O4S
Harmful
Pharmaceutical
White to off-white powder
223-225
429.93